SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-08-009070
Filing Date
2008-08-07
Accepted
2008-08-07 17:24:39
Documents
6
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y65117e10vq.htm 10-Q 371355
2 EX-10.1: COMPENSATORY ARRANGEMENTS FOR EXECUTIVE OFFICERS y65117exv10w1.htm EX-10.1 13734
3 EX-31.1: CERTIFICATION y65117exv31w1.htm EX-31.1 6029
4 EX-31.2: CERTIFICATION y65117exv31w2.htm EX-31.2 6344
5 EX-32.1: CERTIFICATION y65117exv32w1.htm EX-32.1 2923
6 EX-32.2: CERTIFICATION y65117exv32w2.htm EX-32.2 2994
  Complete submission text file 0000950123-08-009070.txt   404875
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15190 | Film No.: 08999643
SIC: 2835 In Vitro & In Vivo Diagnostic Substances